The clinical symptoms of Parkinson's disease.

Sveinbjornsdottir, Sigurlaug·2016·Journal of Neurochemistry

Cited by (1,402)

Items 301–400 of 1,402

  1. FoGGAN: Generating Realistic Parkinson’s Disease Freezing of Gait Data Using GANs
    Νικόλαος Πεππές, Panagiοtis Tsakanikas, Emmanouil Daskalakis · 2023 · Sensors
  2. Comparison of structural connectivity in Parkinson's disease with depressive symptoms versus non-depressed: a diffusion MRI connectometry study
    Mina Ansari, Sahand Adib Moradi, Farzaneh Ghazi Sherbaf, Abozar Hedayatnia, Mohammad Hadi Aarabi · 2018 · International Psychogeriatrics
  3. Cell-free microRNAs in Parkinson’s disease: potential biomarkers that provide new insights into disease pathogenesis
    Epaminondas Doxakis · 2020 · Ageing Research Reviews
  4. Efficacy and safety of magnetic resonance-guided focused ultrasound for Parkinson’s disease: a systematic review and meta-analysis
    Xiaona Tian, Rongrui Hu, Peicong He · 2023 · Frontiers in Neurology
  5. Umbilical cord blood-derived exosomes attenuate dopaminergic neuron damage of Parkinson's disease mouse model
    Junjie Ye, Xiaodong Sun, Qi Jiang, Jianjun Gui, Shenglan Feng, Bingqing Qin, Lixia Xie, Ai Wei Guo, Jinju Dong, Ming Sang · 2024 · Journal of Nanobiotechnology
  6. XEMLPD: an explainable ensemble machine learning approach for Parkinson disease diagnosis with optimized features
    Fahmida Khanom, S. K. Biswas, Mohammad Shorif Uddin, Rafid Mostafiz · 2024 · International Journal of Speech Technology
  7. Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson’s Disease
    Cornelius J. H. M. Klemann, Helena Xicoy, Geert Poelmans, Bas R. Bloem, Gerard J.M. Martens, Jasper E. Visser · 2017 · Molecular Neurobiology
  8. Geranylated carbazole alkaloids with potential neuroprotective activities from the stems and leaves of Clausena lansium
    Liu Yan-ping, Jiaming Guo, Xiaoping Wang · 2019 · Bioorganic Chemistry
  9. miR-185 and SEPT5 Genes May Contribute to Parkinson’s Disease Pathophysiology
    Arman Rahimmi, Ilaria Peluso, Aref Rajabi · 2019 · Oxidative Medicine and Cellular Longevity
  10. Common aspects between glaucoma and brain neurodegeneration
    Sergio Claudio Saccà, Filippo Paluan, Stefano Gandolfi, Gianluca Manni, Carlo Alberto Cutolo, Alberto Izzotti · 2020 · Mutation Research/Reviews in Mutation Research
  11. Parkinson’s Disease Gene Biomarkers Screened by the LASSO and SVM Algorithms
    Yiwen Bao, Lufeng Wang, Fei Yu, Jie Yang, Dongya Huang · 2023 · Brain Sciences
  12. Doença de Parkinson: revisão de literatura / Parkinson’s Disease: literature review
    Ana Beatriz Gomes Silva, Beatriz Carvalho Pestana, Fernanda Akemi Andrade Hirahata, Fernando Brasil de Sousa Horta, Eder Samuel Bonfim Esteves Oliveira · 2021 · Brazilian Journal of Development
  13. Palliative Care for Patients and Families With Parkinson's Disease
    Raquel Bouça‐Machado, Nataliya Titova, К. Ray Chaudhuri, Bas R. Bloem, Joaquim José Ferreira · 2017 · International review of neurobiology
  14. Cicadidae Periostracum, the Cast-Off Skin of Cicada, Protects Dopaminergic Neurons in a Model of Parkinson’s Disease
    Hye‐Sun Lim, Joong‐Sun Kim, Byeong Cheol Moon, Goya Choi, Seung Mok Ryu, Jun Hyung Lee, Mary Jasmin Ang, Mijin Jeon, Changjong Moon, Gunhyuk Park · 2019 · Oxidative Medicine and Cellular Longevity
  15. Nacre-Inspired MXene Nanocomposite-based Strain Sensor with Ultrahigh Sensitivity in a Small Strain Range for Parkinson’s Disease Diagnosis
    Yuzhang Du, Yichen Liu, Wenxuan Lu, Xuan Zhang, Aoao Wang, Jie Kong · 2023 · ACS Applied Materials & Interfaces
  16. Artificial Intelligence in The Management of Neurodegenerative Disorders
    Sanchit Dhankhar, Somdutt Mujwar, Nitika Garg, Samrat Chauhan, Monika Saini, Prerna Sharma, Suresh Kumar, Satish Kumar Sharma, Mohammad Amjad Kamal, Nidhi Rani · 2023 · CNS & Neurological Disorders - Drug Targets
  17. Baohuoside I suppresses the NLRP3 inflammasome activation via targeting GPER to fight against Parkinson's disease
    Yu Gu, Zifan Hu, Danwen Zheng, Yanqing Yang, Xiao‐Li Dong, Wenfang Chen · 2024 · Phytomedicine
  18. Neuroprotective effects of L-Dopa-modified zinc oxide nanoparticles on the rat model of 6-OHDA-ınduced Parkinson’s disease
    Yeşim Yeni, Sıdıka Genç, Muhammed Sait Ertuğrul, Hayrünnisa Nadaroğlu, Arzu Gezer, Ali Sefa Mendĭl, Ahmet Hacımüftüoğlu · 2024 · Scientific Reports
  19. The effectiveness of acupuncture for Parkinson’s disease: An overview of systematic reviews
    Liujiao Cao, Xiuxia Li, Meixuan Li, Liang Yao, Liangying Hou, Weiyi Zhang, Yongfeng Wang, Junqiang Niu, Kehu Yang · 2020 · Complementary Therapies in Medicine
  20. Smell tests to distinguish Parkinson’s disease from other neurological disorders: a systematic review and meta-analysis
    Cintia C. G. Alonso, Fernanda Gonçalves Silva, Leonardo Oliveira Pena Costa, Sandra Maria Sbeghen Ferreira de Freitas · 2021 · Expert Review of Neurotherapeutics
  21. Focus on the Small GTPase Rab1: A Key Player in the Pathogenesis of Parkinson’s Disease
    José A. Martínez‐Menárguez, Emma Martínez‐Alonso, Mireia Cara‐Esteban, Mónica Tomás · 2021 · International Journal of Molecular Sciences
  22. PACAP and VIP Mitigate Rotenone-Induced Inflammation in BV-2 Microglial Cells
    Sarah Thomas Broome, Giuseppe Musumeci, Alessandro Castorina · 2022 · Journal of Molecular Neuroscience
  23. Effectiveness of Therapies Based on Mirror Neuron System to Treat Gait in Patients with Parkinson’s Disease—A Systematic Review
    Silvia Lahuerta-Martín, Rocío Llamas‐Ramos, Inés Llamas‐Ramos · 2022 · Journal of Clinical Medicine
  24. Higher Order Polynomial Transformer for Fine-Grained Freezing of Gait Detection
    Renfei Sun, Kun Hu, Kaylena A. Ehgoetz Martens · 2023 · IEEE Transactions on Neural Networks and Learning Systems
  25. ER ‐phagy in neurodegeneration
    Melissa A. Hill, Alex M. Sykes, George D. Mellick · 2023 · Journal of Neuroscience Research
  26. Identification of distinct blood-based biomarkers in early stage of Parkinson’s disease
    Yingyan Wu, Qian Yao, Guo‐Xin Jiang, Gang Wang, Qi Cheng · 2019 · Neurological Sciences
  27. SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease
    Ana Gómez López, Arantxa Sánchez‐Sánchez, Elena Natera‐Villalba · 2021 · Brain Sciences
  28. Identifying Mild Cognitive Impairment in Parkinson’s Disease With Electroencephalogram Functional Connectivity
    Cai, Min, Dang, Ge, Su, Xiaolin, Zhu, Lin, Shi, Xue, Che, Sixuan, Lan, Xiaoyong, Luo, Xiaoguang, Guo, Yi · 2021 · Frontiers in Aging Neuroscience
  29. Emergence of the brain-border immune niches and their contribution to the development of neurodegenerative diseases
    Li Yang Tan, Grace Cunliffe, Michael Patrick Hogan, Xin Yi Yeo, Chansik Oh, Bohwan Jin, Junmo Kang, Junho Park, Min‐Soo Kwon, MinYoung Kim et al. · 2024 · Frontiers in Immunology
  30. Multimodal Retinal Imaging Classification for Parkinson's Disease Using a Convolutional Neural Network
    Alexander Richardson, Anita Kundu, Ricardo Henao · 2024 · Translational Vision Science & Technology
  31. Small Molecules in Parkinson’s Disease Therapy: From Dopamine Pathways to New Emerging Targets
    Hwa‐Young Lee, Ahmed Elkamhawy, Polina Rakhalskaya, Qili Lu, Hossam Nada, Guofeng Quan, Kyeong Lee · 2024 · Pharmaceuticals
  32. Regulation of Inositol Biosynthesis: Balancing Health and Pathophysiology
    Kendall C. Case, Michael Salsaa, Wenxi Yu, Miriam L. Greenberg · 2018 · Handbook of experimental pharmacology
  33. Detection of Parkinson’s Disease through the Peptoid Recognizing α-Synuclein in Serum
    Houqian Gao, Zijian Zhao, Zhaohui He, Huayi Wang, Mingzhu Liu, Zhiyuan Hu, Oumei Cheng, Yanlian Yang, Ling Zhu · 2019 · ACS Chemical Neuroscience
  34. Visuomotor control of walking in Parkinson’s disease: Exploring possible links between conscious movement processing and freezing of gait
    Lotte E. S. Hardeman, Elmar C. Kal, William R. Young, John van der Kamp, Toby Jack Ellmers · 2020 · Behavioural Brain Research
  35. Lipoprotein-Associated Phospholipase A2 Is a Risk Factor for Patients With Parkinson’s Disease
    Zubo Wu, Suyuan Wu, Tao Liang, Lin Wang · 2021 · Frontiers in Neuroscience
  36. Dysfunction of RAB39B‐ Mediated Vesicular Trafficking in Lewy Body Diseases
    David J. Koss, Susanna Campesan, Flaviano Giorgini, Tiago F. Outeiro · 2021 · Movement Disorders
  37. Interventions Within the Scope of Occupational Therapy to Improve Activities of Daily Living, Rest, and Sleep in People With Parkinson’s Disease: A Systematic Review
    Barbara M. Mollere Doucet, Ingrid Franc, Elizabeth G. Hunter · 2021 · American Journal of Occupational Therapy
  38. Patterns of Sulcal depth and cortical thickness in Parkinson’s disease
    Erlei Wang, Yujing Jia, Yang Ya, Jin Xu, Chengjie Mao, Weifeng Luo, Guohua Fan, Zhen Jiang · 2021 · Brain Imaging and Behavior
  39. Effect of Exercise on Motor Symptoms in Patients With Parkinson's Disease: A Network Meta-analysis
    Celia Álvarez‐Bueno, Jonathan James Deeks, Iván Cavero‐Redondo, Kate B Jolly, Ana Isabel Torres-Costoso, Malcolm James Price, Rubén Fernández‐Rodríguez, Vicente Martínez‐Vizcaíno · 2021 · Journal of Geriatric Physical Therapy
  40. Smartphone-based detection of levodopa in human sweat using 3D printed sensors
    Dalton Lee Glasco, Anjaiah Sheelam, Nguyen H. B. Ho, Jeffrey Gordon Bell · 2023 · Analytica Chimica Acta
  41. Evaluation of the Neurological State of People with Parkinson’s Disease Using i-Vectors
    Nayeli Monserrat Cazares García, Juan Rafael Orozco‐Arroyave, Luis Fernando D’Haro, Najim Dehak, Elmar Nöth · 2017 · Interspeech (USB)
  42. Are There Benefits in Adding Catechol-O Methyltransferase Inhibitors in the Pharmacotherapy of Parkinson’s Disease Patients? A Systematic Review
    Irene Katsaiti, John V. Nixon · 2018 · Journal of Parkinson s Disease
  43. Parkinson’s Disease is Associated with Dysregulations of a Dopamine-Modulated Gene Network Relevant to Sleep and Affective Neurobehaviors in the Striatum
    Peng Jiang, Joseph R. Scarpa, Vance Difan Gao, Martha Hotz Vitaterna, Andrew Kasarskis, Fred William Turek · 2019 · Scientific Reports
  44. Elucidating Critical Proteinopathic Mechanisms and Potential Drug Targets in Neurodegeneration
    Khalid Bashir Dar, Aashiq Hussain Bhat, Shajrul Amin, Bilal Ahmad Reshi, Mohammad Afzal Zargar, Akbar Masood, Showkat Ahmad Ganie · 2019 · Cellular and Molecular Neurobiology
  45. Monascin exhibits neuroprotective effects in rotenone model of Parkinson’s disease via antioxidation and anti-neuroinflammation
    Qiuyu Lin, Sen Hou, Yuyin Dai, Nan Jiang, Yingjie Lin · 2020 · Neuroreport
  46. Towards Parkinson’s Disease Detection Through Analysis of Everyday Handwriting
    Jeferson David Gallo-Aristizábal, Daniel Escobar-Grisales, Cristian David Ríos-Urrego · 2025 · Diagnostics
  47. Recent advances in targeting LRRK2 for Parkinson’s disease treatment
    Mahsa Karami, Pantea Majma Sanaye, Atousa Ghorbani, Roshanak Amirian, Pouya Goleij, Mehregan Babamohamadi, Zhila Izadi · 2025 · Journal of Translational Medicine
  48. The Role of Xenobiotics and Trace Metals in Parkinson’s Disease
    Geir Bjørklund, Maryam Dadar, Salvatore Chirumbolo, Jan Aaseth · 2019 · Molecular Neurobiology
  49. An Overview of Acoustic-Based Interventions to Improve Motor Symptoms in Parkinson’s Disease
    Jessie Siew-Pin Leuk, Linette Li Neng Low, Wei‐Peng Teo · 2020 · Frontiers in Aging Neuroscience
  50. Parkinson's disease: Are gut microbes involved?
    Abass Olawale Omotosho, Yusuf Amuda Tajudeen, Habeebullah Jayeola Oladipo, Sodiq Inaolaji Yusuff, Muritala Abdulkadir, Abdulbasit Opeyemi Muili, Oluwaseyi Muyiwa Egbewande, Rashidat Onyinoyi Yusuf, Zaccheaus Oluwaseun Faniran, Abdullateef Opeyemi Afolabi et al. · 2023 · Brain and Behavior
  51. No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson’s disease-related cognitive impairment
    Rachel A. Crockett, K. B. Wilkins, S. Aditham, H. Brontë-Stewart · 2023 · Neurobiology of Disease
  52. Imaging Protein Aggregates in Parkinson’s Disease Serum Using Aptamer-Assisted Single-Molecule Pull-Down
    Yu P. Zhang, Evgeniia Lobanova, Derya Emin, Sergey V. Lobanov, Antonina Kouli, Caroline H. Williams‐Gray, David Klenerman · 2023 · Analytical Chemistry
  53. A Transfer Learning Approach with MobileNetV2 for Parkinson’s Disease Detection using Hand-Drawings
    B. Anil Kumar, Mohan Bansal · 2023 · International Conference on Computing, Communication and Networking Technologies (ICCCNT)
  54. Neuroprotective effect of green tea extract (-)-epigallocatechin-3-gallate in a preformed fibril-induced mouse model of Parkinson’s disease
    Jianing Shen, Junhua Xie, Liyuan Ye, Jian Mao, Shihao Sun, Weiwei Chen, Sijia Wei, Sisi Ruan, Linhai Wang, Hangcui Hu et al. · 2024 · Neuroreport
  55. Immune system and new avenues in Parkinson’s disease research and treatment
    Ava Nasrolahi, Fatemeh Safari, Mehdi Farhoudi, Afra Khosravi, Fereshteh Farajdokht, Saiyad Bastaminejad, Siamak Sandoghchian Shotorbani, Javad Mahmoudi · 2019 · Reviews in the Neurosciences
  56. Mulberrin attenuates 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced Parkinson’s disease by promoting Wnt/β-catenin signaling pathway
    Wenhui Cao, Yan Dong, Weina Zhao · 2019 · Journal of Chemical Neuroanatomy
  57. Neuroendocrine Disturbances in Neurodegenerative Disorders: A Scoping Review
    Amy L. Newhouse, Zeina N. Chemali · 2019 · Psychosomatics
  58. How Parkinson's disease-related mutations disrupt the dimerization of WD40 domain in LRRK2: a comparative molecular dynamics simulation study
    Xinyi Li, Mingyu Ye, Yue Wang, Ming Qiu, Tingting Fu, Jian Zhang, Bin Zhou, Shaoyong Lu · 2020 · Physical Chemistry Chemical Physics
  59. Modulation of cellular redox environment as a novel therapeutic strategy for Parkinson's disease
    Cláudia M. Deus, José Teixeira, Nuno Raimundo, Paolo Tucci, Fernanda Borges, Luciano Saso, Paulo Jorge Oliveira · 2022 · European Journal of Clinical Investigation
  60. The Impact of Probiotics on Clinical Symptoms and Peripheral Cytokines Levels in Parkinson’s Disease: Preliminary In Vivo Data
    Luca Magistrelli, Elena Contaldi, Annalisa Visciglia, Giovanni Deusebio, Marco Pane, Angela Amoruso · 2024 · Brain Sciences
  61. Investigation of anti-Parkinson activity of dicyclomine
    Maham Sanawar, Uzma Saleem, Fareeha Anwar, Samra Nazir, Muhammad Furqan Akhtar, Bashir Ahmad, Tariq Ismail · 2020 · International Journal of Neuroscience
  62. Effect of Acupuncture on Movement Function in Patients with Parkinson’s Disease: Network Meta-Analysis of Randomized Controlled Trials
    Miri Kwon, Moon Joo Cheong, Jungtae Leem, Tae‐Hun Kim · 2021 · Healthcare
  63. LRRK2‐G2019S mice display alterations in glutamatergic synaptic transmission in midbrain dopamine neurons
    Olga Skiteva, Ning Yao, Giacomo Sitzia, Karima Chergui · 2022 · Journal of Neurochemistry
  64. Neural stem cell secretome exerts a protective effect on damaged neuron mitochondria in Parkinson's disease model
    Wei Min NI, Jiqin Zhou, Yating Ling, Xiaorui Lu, Dongdong Niu, Yu Zeng, Yun Qiu, Yu Si, Jia Wang, Weining Zhang et al. · 2022 · Brain Research
  65. LRRK2 and Proteostasis in Parkinson’s Disease
    María Dolores Pérez‐Carrión, Inmaculada Posadas, Javier Solera, Valentı́n Ceña · 2022 · International Journal of Molecular Sciences
  66. A comprehensive examination of the evidence for whole of diet patterns in Parkinson's disease: a scoping review
    Joanna Rees, Jillian Claire Ryan, Manja Laws, Amanda Devine · 2023 · Nutritional Neuroscience
  67. Huperzine A injection ameliorates motor and cognitive abnormalities via regulating multiple pathways in a murine model of Parkinson's disease
    Xinran Guo, Yuhan Wu, Qingqing Wang, Jianbing Zhang, Xueping Sheng, Lanrong Zheng, Yule Wang · 2023 · European Journal of Pharmacology
  68. 199 years of Parkinson disease – what have we learned and what is the path to the future?
    Jörg Bernhard Schulz, Laura Hausmann, John Hardy · 2016 · Journal of Neurochemistry
  69. Earliest Mechanisms of Dopaminergic Neurons Sufferance in a Novel Slow Progressing Ex Vivo Model of Parkinson Disease in Rat Organotypic Cultures of Substantia Nigra
    Matteo Dal Ben, Rosario Bongiovanni, Simone Tuniz, Emanuela Fioriti, Claudio Tiribelli, Rita Moretti, Silvia Gazzin · 2019 · International Journal of Molecular Sciences
  70. Clinical and Neuropathological Features Associated With Loss of RAB39B
    Yujing Gao, Verónica Martínez‐Cerdeño, Kirk J. Hogan, Catriona McLean, Paul J. Lockhart · 2020 · Movement Disorders
  71. Bioinformatics Approach to Identify Significant Biomarkers, Drug Targets Shared Between Parkinson’s Disease and Bipolar Disorder: A Pilot Study
    Md. Bipul Hossain, Md. Kobirul Islam, Apurba Adhikary, Abidur Rahaman, Md Zahidul Islam · 2022 · Bioinformatics and Biology Insights
  72. Evidence for using pimavanserin for the treatment of Parkinson's disease psychosis
    Rajesh R. Tampi, Deena J. Tampi, Juan Joseph Young, Silpa Balachandran, Rakin Hoq, Geetha Manikkara · 2019 · World Journal of Psychiatry
  73. Neuroprotective Effect of Maresin-1 in Rotenone-Induced Parkinson’s Disease in Rats: The Putative Role of the JAK/STAT Pathway
    Suzan A Khodir, Eman M. Sweed, Manar A. Faried, Doaa M. Abo EL-KHAİR, Marwa M. Khalil, Khaled Hatem Afifi, Dalia Fathy El Agamy · 2024 · Neurochemical Research
  74. A novel integrative multimodal classifier to enhance the diagnosis of Parkinson’s disease
    Xiaoyan Zhou, Luca Parisi, Wentao Huang, Yihan Zhang, Xiaoqun Huang, Mansour Youseffi, Farideh A. Javid, Renfei Ma · 2025 · Briefings in Bioinformatics
  75. Tamoxifen usage correlates with increased risk of Parkinson’s disease in older women with breast cancer: a case–control study in Taiwan
    Hsien-Feng Lin, Kuan‐Fu Liao, Ching-Mei Chang · 2017 · European Journal of Clinical Pharmacology
  76. Development of hypotension in patients newly diagnosed with heart failure in UK general practice: retrospective cohort and nested case–control analyses
    Mar Martín‐Pérez, Alexander Michel, Mark Ma, Luis Alberto García Rodríguez · 2019 · BMJ Open
  77. Biologically active compounds from Lamiaceae family: Central nervous system effects
    Abeer Abdelhalim, Jane R. Hanrahan · 2021 · Studies in natural products chemistry
  78. Impact of fatty acid-binding proteins and dopamine receptors on α-synucleinopathy
    K. Kawahata, Kohji Fukunaga · 2021 · Journal of Pharmacological Sciences
  79. Polyphenolic Glycosides from the Fruits Extract of Lycium ruthenicum Murr and Their Monoamine Oxidase B Inhibitory and Neuroprotective Activities
    Yi‐Kao Hu, Xiaolin Bai, Hao Yuan, Yi Zhang, Emmanuel Ayodeji Ayeni, Xun Liao · 2022 · Journal of Agricultural and Food Chemistry
  80. MiR-29a inhibits MPP + - Induced cell death and inflammation in Parkinson's disease model in vitro by potential targeting of MAVS
    Ya‐Ling Yang, Tsu‐Kung Lin, Ying‐Hsien Huang · 2022 · European Journal of Pharmacology
  81. The effect of Computer Assisted Rehabilitation Environment (CAREN) in cognitive impairment and coping strategies in Parkinson's disease: a preliminary study
    Caterina Formica, Lilla Bonanno, Dèsiréè Latella, Maria Cristina Ferrera, Giuseppa Maresca, Anna Lisa Logiudice, Chiara Sorbera, Amelia Brigandì, Giuseppe Di Lorenzo, Silvia Marino · 2023 · Scientific Reports
  82. Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model ofGBA1-associated Parkinson’s disease
    Manoj Kumar, Manasa P. Srikanth, Michela Deleidi, Penelope J. Hallett, Ole Isacson A, Ricardo A. Feldman · 2023 · Human Molecular Genetics
  83. Pathogenic LRRK2 compromises the subcellular distribution of lysosomes in a Rab12‐RILPL1 ‐dependent manner
    Kyohei Ito, Miho Araki, Yuta Katai, Yuki Nishimura, Sota Imotani, Haruki Inoue, Genta Ito, Taisuke Tomita · 2023 · The FASEB Journal
  84. The effects of exercise dose on patients with Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials
    Wenlai Cui, Dong Li, Leijiao Yue, Jun Xie · 2023 · Journal of Neurology
  85. GLP-1/Sigma/RAGE receptors: An evolving picture of Alzheimer's disease pathology and treatment
    Neha Neha, Zitin Wali, Pinky Pinky, Shaheenkousar H. Hattiwale, Azfar Jamal, Suhel Parvez · 2023 · Ageing Research Reviews
  86. Effects of non-invasive vagus nerve stimulation on clinical symptoms and molecular biomarkers in Parkinson’s disease
    Banashree Mondal, Supriyo Choudhury, Rebecca Banerjee, Akash Roy, Koustav Chatterjee, Purba Basu, Ravi Singh, Saptak Halder, Shantanu Shubham, Stuart N. Baker et al. · 2024 · Frontiers in Aging Neuroscience
  87. Insights into Parkinson’s Disease-Related Freezing of Gait Detection and Prediction Approaches: A Meta Analysis
    Hagar Elbatanouny, Natasa Kleanthous, Hayssam Dahrouj, Sundus H. Alusi, E'qab R. Almajali, Soliman Awad Mahmoud, Abir Jaffar Hussain · 2024 · Sensors
  88. Astrocytic Expression of GSTA4 Is Associated to Dopaminergic Neuroprotection in a Rat 6-OHDA Model of Parkinson’s Disease
    Michael A S Jewett, Itzia Jiménez-Ferrer, Maria Swanberg · 2017 · Brain Sciences
  89. Prenatal exposure to oxidative phosphorylation xenobiotics and late-onset Parkinson disease
    Eldris Iglesias, Alba Pesini, Nuria Garrido-Pérez, Patricia Meade, M. Pilar Bayona‐Bafaluy, Julio Montoya, Eduardo Ruiz‐Pesini · 2018 · Ageing Research Reviews
  90. Synthesis and biological evaluation of clovamide analogues with catechol functionality as potent Parkinson’s disease agents in vitro and in vivo
    Jiahao Feng, Xiaolong Hu, Xian-Yu Lv, Bao-Lin Wang, Jun Lin, Xiao‐Qi Zhang, Wen‐Cai Ye, Fei Xiong, Hao Wang · 2018 · Bioorganic & Medicinal Chemistry Letters
  91. Activities of daily living as a longitudinal moderator of the effect of autonomic dysfunction on anxiety and depression of Parkinson's patients
    Jing Cui, Yao Qin, Yuling Tian, Xiaoyan Ge, Hongjuan Han, Zongfang Yang, Hongmei Yu · 2021 · Brain and Behavior
  92. Targeting Leucine-Rich Repeat Kinase 2 (LRRK2) for the Treatment of Parkinson's Disease
    Sofia Domingos, M. Teresa Duarte, Lucı́lia Saraiva · 2019 · Future Medicinal Chemistry
  93. Recent advances in molecularly imprinted polymers toward biomedical healthcare devices
    Youngjun Seo, Yong-Hwan Kim, Jaeheung Kim, Hyo Gi Jung, Jae Won Jang, Hyunji Kim, Kyo Seon Hwang, Dongtak Lee, Sang Won Lee, Jeong Hoon Lee et al. · 2025 · Biosensors and Bioelectronics
  94. Entrenamiento antigravitatorio e inmersivo de realidad virtual para la rehabilitación de la marcha en la enfermedad de Parkinson: estudio piloto y de viabilidad
    Natalia Brandín‐de la Cruz, Nicolás Secorro, Sandra Calvo · 2020 · Revista de Neurología
  95. Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal—Intestinal Inflammation Activited and Intestinal Microbiota—Metabolic Disorders Induced in MPTP Mouse Model of Parkinson’s Disease
    Xinrong Liu, Shuya Liu, Yong Tang, Zhengjia Pu, Hong Xiao, Jieying Gao, Qi Yin, Yan Jia, Qunhua Bai · 2021 · Neurochemical Research
  96. Effects of dry needling on gait and muscle tone in Parkinson’s disease: a randomized clinical trial
    Natalia Brandín‐de la Cruz, Sandra Calvo, Cleofás Rodríguez‐Blanco, Pablo Herrero, Elisabeth Bravo-Esteban · 2021 · Acupuncture in Medicine
  97. Impact of Data Preparation in Freezing of Gait Detection Using Feature-Less Recurrent Neural Network
    Ali Haddadi Esfahani, Zoya Dyka, Steffen Ortmann, Peter Langendörfer · 2021 · IEEE Access
  98. Identification of Altered Blood MicroRNAs and Plasma Proteins in a Rat Model of Parkinson’s Disease
    Sanjeev Kumar Yadav, Anuj Kumar Pandey, Sana Sarkar, Smriti Yadav, Devendra Parmar, Sanjay Yadav · 2022 · Molecular Neurobiology
  99. Circular RNA hsa_circ_0004381 Promotes Neuronal Injury in Parkinson’s Disease Cell Model by miR-185-5p/RAC1 Axis
    Hongying Zhang, Cuihui Wang, Xuejie Zhang · 2022 · Neurotoxicity Research
  100. Pose-Based Tremor Classification for Parkinson’s Disease Diagnosis from Video
    Haozheng Zhang, Edmond S. L. Ho, Xiatian Zhang · 2022 · Lecture notes in computer science